AN2 Therapeutics

ANTX · NASDAQ

$3.56+$0.19 (+5.64%)TodayMarket closed ·
Prev close $3.37

Who owns ANTX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 58.6% of ANTX’s shares.

  • Vivo Capital, LLC8.8%
  • Coastlands Capital LP8.5%
  • Commodore Capital LP8.1%
  • Adjuvant Global Health Technology Fund LP6.6%
  • Next 6 largest institutions26.6%
  • All other shareholders41.4%
Top institutional holders of ANTX
HolderShares% of shares
Vivo Capital, LLC3.15M8.76%
Coastlands Capital LP3.07M8.53%
Commodore Capital LP2.93M8.14%
Adjuvant Global Health Technology Fund LP2.37M6.59%
Millennium Management LLC2.32M6.44%
Spruce Street Capital LP1.66M4.61%
BlackRock Institutional Trust Company, N.A.1.51M4.20%
Almitas Capital LLC1.47M4.08%
Easom (Eric)1.36M3.77%
Readnour (Robin Shane)1.24M3.45%

Largest mutual fund holders

Top mutual fund holders of ANTX
HolderShares% of shares
Vanguard Total Stock Market Index Fund853.02K2.37%
iShares Russell 2000 ETF600.47K1.67%
MEDICAL BioHealth504.73K1.40%
Vanguard Extended Market Index Fund360.11K1.00%
APO Medical Opportunities330.55K0.92%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $11.60K (1 trade) and sold $344.18K (11 trades) of ANTX on the open market.

Latest ANTX insider transactions
InsiderTypeSharesValue
Marks Gilbert LynnAward2.28K—
Martin Patricia A.Award389—
Aziz KabeerAward2.46K—
Trenor Cameron C. IIIAward233.33K—
Trenor Cameron C. IIIAward116.67K—
Readnour Robin ShaneSale585$3.52K
Readnour Robin ShaneSale523$3.15K
Readnour Robin ShaneSale5.29K$31.86K
Readnour Robin ShaneSale4.72K$28.44K
Readnour Robin ShaneSale3.22K$19.56K

Short interest

Settled Sep 30, 2026

Shares short
2.49M
Days to cover
9.54
% of shares outstanding
6.92%
Average daily volume
261.16K
Change since last report
+3.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.